Sarrazin C - Search Results

1

A multicenter study on the role of direct retrograde cholangioscopy in patients with inconclusive endoscopic retrograde cholangiography.

Farnik H, Weigt J, Malfertheiner P, Grützmann A, Gossner L, Friedrich-Rust M, Zeuzem S, Sarrazin C, Albert JG. Farnik H, et al. Among authors: sarrazin c. Endoscopy. 2014 Jan;46(1):16-21. doi: 10.1055/s-0033-1359043. Epub 2013 Dec 18. Endoscopy. 2014. PMID: 24353122

2

Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses.

Sarrazin C, Herrmann E, Bruch K, Zeuzem S. Sarrazin C, et al. J Virol. 2002 Nov;76(21):11079-90. doi: 10.1128/jvi.76.21.11079-11090.2002. J Virol. 2002. PMID: 12368350 Free PMC article.

3

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy.

Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, Wiedenmann B, Hopf U, Zeuzem S. Berg T, et al. Among authors: sarrazin c. Hepatology. 2003 Mar;37(3):600-9. doi: 10.1053/jhep.2003.50106. Hepatology. 2003. PMID: 12601358

4

Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.

Hofmann WP, Sarrazin C, Kronenberger B, Schönberger B, Bruch K, Zeuzem S. Hofmann WP, et al. Among authors: sarrazin c. J Infect Dis. 2003 Mar 15;187(6):982-7. doi: 10.1086/368221. Epub 2003 Mar 6. J Infect Dis. 2003. PMID: 12660945 Clinical Trial.

5

Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C.

Mihm U, Herrmann E, Sarrazin U, von Wagner M, Kronenberger B, Zeuzem S, Sarrazin C. Mihm U, et al. Among authors: sarrazin u, sarrazin c. J Hepatol. 2004 May;40(5):845-52. doi: 10.1016/j.jhep.2004.01.007. J Hepatol. 2004. PMID: 15094234

6

Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy.

Hofmann WP, Zeuzem S, Sarrazin C. Hofmann WP, et al. Among authors: sarrazin c. J Clin Virol. 2005 Feb;32(2):86-91. doi: 10.1016/j.jcv.2004.08.004. J Clin Virol. 2005. PMID: 15653410 Review.

7

Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue.

Hofmann WP, Dries V, Herrmann E, Gärtner B, Zeuzem S, Sarrazin C. Hofmann WP, et al. Among authors: sarrazin c. J Clin Virol. 2005 Apr;32(4):289-93. doi: 10.1016/j.jcv.2004.08.011. J Clin Virol. 2005. PMID: 15780807

8

Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir-lamivudine combination therapy.

Mihm U, Gärtner BC, Faust D, Hofmann WP, Sarrazin C, Zeuzem S, Herrmann E. Mihm U, et al. Among authors: sarrazin c. J Hepatol. 2005 Aug;43(2):217-24. doi: 10.1016/j.jhep.2005.02.037. J Hepatol. 2005. PMID: 15964093

9

Current therapy for hepatitis C.

Friedrich-Rust M, Zeuzem S, Sarrazin C. Friedrich-Rust M, et al. Among authors: sarrazin c. Int J Colorectal Dis. 2007 Apr;22(4):341-9. doi: 10.1007/s00384-005-0038-9. Epub 2005 Sep 21. Int J Colorectal Dis. 2007. PMID: 16175369 Review.

10

Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.

Sarrazin C, Mihm U, Herrmann E, Welsch C, Albrecht M, Sarrazin U, Traver S, Lengauer T, Zeuzem S. Sarrazin C, et al. Among authors: sarrazin u. J Infect Dis. 2005 Nov 15;192(10):1710-9. doi: 10.1086/497142. Epub 2005 Oct 14. J Infect Dis. 2005. PMID: 16235168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters